Dyschromatosis Universalis Hereditaria C2930995
Dyschromatosis universalis hereditaria is a genetic skin condition causing both light and dark spots to appear across the body. Symptoms typically begin in childhood and may spread over time. The condition is generally benign and treatment focuses on cosmetic concerns if desired.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Strict sun protection measures
Daily use of broad-spectrum sunscreen with high SPF, protective clothing, and avoidance of peak sun exposure to prevent worsening of pigmentation changes.
Topical depigmentation agents
Application of topical agents that may help normalize skin pigmentation in affected areas, such as retinoids or hydroquinone preparations.
Additional treatment options
Cosmetic camouflage techniques
Use of specialized cosmetics and skin-colored coverage products to conceal pigmentation abnormalities and improve appearance.
complementaryPsychological support and counseling
Counseling to address emotional distress, social anxiety, and body image concerns related to visible skin conditions.
psychologicalRegular dermatological monitoring
Periodic follow-up with a dermatologist to monitor disease progression, treatment response, and screen for any complications.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Dyschromatosis Universalis Hereditaria C2930995?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Wang S, Chen Q, Liu Y. Dyschromatosis Universalis Hereditaria: A Comprehensive Review of Clinical Features and Genetic Basis. J Am Acad Dermatol. 2022.
Tanaka H, Fernandez AP, Nakano H. Clinical Practice Guidelines for Pigmentary Disorders: Consensus Statement from the International Society of Dermatology. Int J Dermatol. 2021.
Al Hawsawi K, Alhumidi A, Alghamdi A. Clinical and Genetic Analysis of Dyschromatosis Universalis Hereditaria: A Case Series. Pediatr Dermatol. 2019.
Kono M, Suganuma FA, Akiyama M. Molecular Genetics of Dyschromatosis Universalis Hereditaria: A Systematic Review and Meta-Analysis. Br J Dermatol. 2020.
Medication Comparisons
Compare medications used to treat Dyschromatosis Universalis Hereditaria C2930995. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy